Lincoln Pharmaceuticals Ltd. Share Price & Stock Analysis

Lincoln Pharmaceuticals Ltd. (BSE: 531633) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹1,038 Cr, it ranks #1,563 by market cap among the 6,197 Indian listed companies on FinBizNet, and #24 of 63 in Pharmaceuticals. At ₹525.95 (as of 16 Nov 2026), the share price is 31.7% below its 52-week high of ₹770.00 and 19.5% above its 52-week low of ₹440.00. The share price is down 0.2% over one year and down 15.7% over three months.

Key Metrics

Current Price₹525.95
Market Cap₹1,038 Cr
BSE Code531633
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio11.8
Return on Equity12.30%
Return on Assets6.23%
52-Week Range₹440.00 – ₹770.00
1-Year Price Change-0.2%
3-Month Price Change-15.7%
Beta (1Y)0.32
Dividend Yield0.35%
HeadquartersAhmedabad, Gujarat
Websitewww.lincolnpharma.com

Latest Quarterly Results — Q2 FY27

Revenue₹191 Cr
Net Profit₹20 Cr
Net Margin10.7%
EPS (Basic)₹10.20
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Lincoln Pharmaceuticals Ltd. Quarterly Revenue and Profit Trend

Lincoln Pharmaceuticals Ltd. reported revenue of ₹191 Cr in Q2 FY27, up 17.1% from ₹163 Cr in Q2 FY26 and up 7.9% from ₹177 Cr in Q1 FY27. It posted a net profit of ₹20 Cr for the quarter, against a net profit of ₹20 Cr in Q2 FY26 (up 2.3%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹154 Cr (Q1 FY26) to ₹191 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹191 Cr₹20 Cr10.7%
Q1 FY27₹177 Cr₹36 Cr20.4%
Q4 FY26₹187 Cr₹12 Cr6.2%
Q3 FY26₹166 Cr₹29 Cr17.2%
Q2 FY26₹163 Cr₹20 Cr12.2%
Q1 FY26₹154 Cr₹28 Cr18.0%
Q4 FY25₹168 Cr₹12 Cr6.9%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 49.78% of Lincoln Pharmaceuticals Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 44.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.

Products and Services

1. Phamaceuticals-This segment manufactures and sells pharmaceutical products. It offers products in the areas of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin’s, analgesic, anesthetics, respiratory, anti-pyretic, and GIT, as well as vitamins-minerals and iron preparations. 2. Chemical-This segment distributes chemicals products. 3. Segment Adjustment-0 4. Corporate-0

Business Segments

1. Pharmaceuticals Business-100%

Lincoln Pharmaceuticals Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Lincoln Pharmaceuticals Ltd.₹1,038 Cr11.812.30%₹191 Cr-0.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Lincoln Pharmaceuticals Ltd.?

Lincoln Pharmaceuticals Ltd. is trading at ₹525.95, with a market capitalisation of ₹1,038 Cr.

Which sector does Lincoln Pharmaceuticals Ltd. belong to?

Lincoln Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Lincoln Pharmaceuticals Ltd.?

Lincoln Pharmaceuticals Ltd. has a P/E of 11.8 and a return on equity of 12.30%.

What is the stock symbol of Lincoln Pharmaceuticals Ltd.?

Lincoln Pharmaceuticals Ltd. is listed on the BSE under the scrip code 531633.

How has Lincoln Pharmaceuticals Ltd.'s share price moved over the past year?

Lincoln Pharmaceuticals Ltd.'s share price is down 0.2% over one year and down 15.7% over three months. Its 52-week range is ₹440.00 to ₹770.00.

What were Lincoln Pharmaceuticals Ltd.'s latest quarterly results?

In Q2 FY27, Lincoln Pharmaceuticals Ltd. reported revenue of ₹191 Cr and net profit of ₹20 Cr, with basic EPS of ₹10.2 (consolidated, parsed from the company's exchange filing).

How have Lincoln Pharmaceuticals Ltd.'s revenue and profit changed over the past year?

Lincoln Pharmaceuticals Ltd. reported revenue of ₹191 Cr in Q2 FY27, up 17.1% from ₹163 Cr in Q2 FY26 and up 7.9% from ₹177 Cr in Q1 FY27.

What is the promoter holding in Lincoln Pharmaceuticals Ltd.?

Promoters held 49.78% of Lincoln Pharmaceuticals Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.